Showing results (601-610 of 739) with videos related to
Sort By:
Pageof 74
Vaccine|May 14, 2013
Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenarioSharon E Frey, Patricia L Winokur, Robert A Salata, et al.Leukemia Research|June 11, 2020
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I studyAaron D Goldberg, Ehab Atallah, David Rizzieri, et al.Blood|January 7, 2022
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AMLGabrielle Paras, Linde M Morsink, Megan Othus, et al.The Pediatric Infectious Disease Journal|September 16, 2014
Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in childrenKaren L Kotloff, Natasha B Halasa, Christopher J Harrison, et al.Vaccine|August 4, 2019
Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescentsFlor M Munoz, Evan J Anderson, David I Bernstein, et al.Vaccine|December 11, 2025
Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trialEmmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, et al.Vaccine|June 25, 2011
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adultsRobert W Frenck, Robert Belshe, Rebecca C Brady, et al.Blood Advances|February 10, 2025
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaquesNicholas E Petty, Stefan Radtke, Greta Kanestrom, et al.The Journal of Antimicrobial Chemotherapy|March 25, 2006
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USAMichael D Green, Bernard Beall, Mario J Marcon, et al.Cancers|August 23, 2020
Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationLinde M Morsink, Brenda M Sandmaier, Megan Othus, et al.Pageof 74